FasterCures, a center of the Milken Institute, designed this guide for patient advocacy organizations that are interested in hosting, or are currently planning, an externally led patient-focused drug development (PFDD) meeting. We have created other tools for planning PFDD meetings, including the PFDD Meeting Tracker, the PFDD Readiness Assessment, and the PFDD Community Toolbox. We recommend using this guide in concert with those tools and related resources from the US Food and Drug Administration (FDA).
The team at FasterCures conducted interviews with veteran hosts of externally led PFDD meetings to gather their insights. During the interviews, we found that many leaders shared a similar experience: while planning, they received guidance from those who had planned meetings before them. Organizations were willing to share advice, but the process wasn’t centralized or efficient. In response, we have taken what we heard from those leaders and synthesized our findings into this guide to provide common practices, lessons learned, and considerations for patient organizations that might host a PFDD meeting or who have already begun the planning process.
Related Content
-
Milken Institute Global Conference Goes Virtual October 12-21, 2020
Los Angeles – August 5, 2020 – The Milken Institute Global Conference, an annual convening of global leaders in government, finance, health, academia, and philanthropy, will go fully virtual this fall from October 12-21, 2020. Building on...Read Article -
Venture Philanthropy Legal Report: The Importance of An Interruption License
This report is one in a series on legal issues of interest to non-profit organizations engaged in or thinking about Venture Philanthropy work. It discusses the beginnings of Venture Philanthropy in drug development, the importance of an...Read Report -
Rx for Innovation: Recommendations for the New Administration
FasterCures wants President-elect Donald Trump to be ready to address biomedical innovation on day one. Biomedical innovation is vital to America's health and economic well-being. However, these benefits, and U.S. leadership in the life...Read Report -
Advancing Tech-Enabled Health and Home Care
Over the last two-plus years, the Milken Institute Center for the Future of Aging has explored the financial and care-delivery gaps in the long-term care market, specifically the barriers to affordable care for middle-income households and...Read Report11
Lauren Dunning and Caroline Servat -
Shaping Environments to Shape Us: The Case for Longevity Cities
This report presents the case for Longevity Cities to tackle the challenges of global population aging.Read Report11 11 11Upali Nanda, PhD, Harris Eyre, MD, PhD, and Rajiv Ahuja -
The Reinvention of Prevention: How to Fund and Finance a Pivot to a Prevention-First Healthcare System
As part of the debut of the Milken Institute’s Project Prevent initiative in 2024, the Institute conducted a series of interviews with 35 key stakeholders and experts in health, finance, philanthropy, pensions, and public policy to explore...Read Report -
World Leaders Heading to California for Milken Institute Global Conference: April 29-May 2
LOS ANGELES—More than 4,000 international leaders in business, government, science, philanthropy, academia, arts, and culture will meet in California for the 21 st Milken Institute Global Conference beginning April 29, 2018. Confirmed...Read Article -
The White House Conference on Hunger, Nutrition, and Health
Investing in the intersection of food and healthcare is critical to achieving nutrition equity. Feeding Change submitted a letter informed by the Food Is Medicine Task Force that provides comments to inform the national strategy for the...Read LetterImageHolly Freishtat
Senior Director, Feeding Change, Milken Institute HealthHolly Freishtat is the senior director of Feeding Change at the Milken Institute. She is an experienced director, transformative leader, and strategist with a 20-year track record developing and implementing food system policies and programs. -
Everything You Ever Wanted To Know About Venture Philanthropy Transactions But Were Afraid To Ask
Since 1989, Schaner & Lubitz, PLLC has closed many transactions for disease foundation clients in the field that has come to be known as Venture Philanthropy. Though each charity and transaction have unique aspects, there are some issues...Read Report -
Building Workforce Capacity to Improve Detection and Diagnosis of Dementia
The Alliance to Improve Dementia Care, part of the Milken Institute’s Center for the Future of Aging, utilizes a multi-sector approach to develop recommendations to improve care for individuals living with dementia across all stages...Read Report11Mac McDermott and Diane Ty -
Amyotrophic Lateral Sclerosis (ALS) A Giving Smarter Guide
ALS, commonly known as Lou Gehrig’s disease or motor neurone disease (MND), is a cruel disease that has challenged patients, their families, and the medical community for generations. Although ALS is considered rare, its impact on...Read Report11
-
Implementing Nigeria’s National Strategic Cancer Control Plan and Cancer Research Agenda
Cancer incidence in Nigeria is growing, and mortality rates are high. This report summarizes the roundtable themes and insights, key takeaways, and actionable recommendations.Read Report